AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced the opening of its newest global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The new state-of-the-art facility builds on the Company’s existing presence in Cambridge and Boston and places its scientists at the heart of one of the world’s most innovative…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks